Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Home Print this page Email this page Small font size Default font size Increase font size Users Online: 86
CME ARTICLE
Year : 2019  |  Volume : 20  |  Issue : 1  |  Page : 1-4

Atopic dermatitis: Update on comorbidities and therapeutic advances


1 Pacific Northwest University of Health Sciences, Yakima, WA, USA
2 University of Washington School of Medicine, Seattle, WA, USA
3 University of Washington School of Medicine; Department of Pediatrics, Division of Dermatology, Seattle Children's Hospital, University of Washington School of Medicine, Seattle, WA, USA

Correspondence Address:
Prof. Robert Sidbury
Department of Pediatrics, Division of Dermatology, Seattle Childrenfs Hospital, University of Washington School of Medicine, Seattle, WA 98105
USA
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijpd.IJPD_92_18

Rights and Permissions

Atopic dermatitis (AD) is a chronic inflammatory disorder that primarily affects the skin. Recent literature has expanded our knowledge of associated comorbidities. In this review, we will discuss sleep loss, attention deficit hyperactivity disorder, obesity, and anemia as they relate to AD. We will also review two recently approved medications and how they fit into the therapeutic ladder.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed824    
    Printed9    
    Emailed0    
    PDF Downloaded256    
    Comments [Add]    

Recommend this journal